1 - 25 of
50
results
for author:"Teh B.T."
in Literature Citations
| Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. van Haaften G., Dalgliesh G.L., Davies H., Chen L., Bignell G., Greenman C., Edkins S., Hardy C., O'Meara S., Teague J. et al. Nat. Genet. 41:521-523(2009) · Mapped (12) |
| Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer. Macher-Goeppinger S., Aulmann S., Tagscherer K.E., Wagener N., Haferkamp A., Penzel R., Brauckhoff A., Hohenfellner M., Sykora J., Walczak H. et al. Clin. Cancer Res. 15:650-659(2009) · Mapped (3) |
| Radiosensitization by inhibiting STAT1 in renal cell carcinoma. Hui Z., Tretiakova M., Zhang Z., Li Y., Wang X., Zhu J.X., Gao Y., Mai W., Furge K., Qian C.N. et al. Int. J. Radiat. Oncol. Biol. Phys. 73:288-295(2009) · Mapped (6) |
| Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesis. Tsao C.C., Teh B.T., Jonasch E., Shreiber-Agus N., Efstathiou E., Hoang A., Czerniak B., Logothetis C., Corn P.G. Cancer Biol. Ther. 7:1619-1627(2008) · Mapped (16) |
| Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. Howell V.M., Gill A., Clarkson A., Nelson A.E., Dunne R., Delbridge L.W., Robinson B.G., Teh B.T., Gimm O., Marsh D.J. J. Clin. Endocrinol. Metab. 94:434-441(2009) · Mapped (6) |
| Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. Chen J., Futami K., Petillo D., Peng J., Wang P., Knol J., Li Y., Khoo S.K., Huang D., Qian C.N. et al. PLoS ONE 3:e3581-e3581(2008) · Mapped (2) |
| Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated oxygen-sensing response. Koeman J.M., Russell R.C., Tan M.H., Petillo D., Westphal M., Koelzer K., Metcalf J.L., Zhang Z., Matsuda D., Dykema K.J. et al. PLoS Genet. 4:e1000176-e1000176(2008) · Mapped (2) |
| The E2F3-Oncomir-1 axis is activated in Wilms' tumor. Kort E.J., Farber L., Tretiakova M., Petillo D., Furge K.A., Yang X.J., Cornelius A., Teh B.T. Cancer Res. 68:4034-4038(2008) · Mapped (5) |
| Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Sarquis M.S., Silveira L.G., Pimenta F.J., Dias E.P., Teh B.T., Friedman E., Gomez R.S., Tavares G.C., Eng C., De Marco L. Surgery 143:630-640(2008) · Mapped (2) |
| Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice. Wang P., Bowl M.R., Bender S., Peng J., Farber L., Chen J., Ali A., Zhang Z., Alberts A.S., Thakker R.V. et al. Mol. Cell. Biol. 28:2930-2940(2008) · Mapped (2) |
| Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. Morris M.R., Gentle D., Abdulrahman M., Clarke N., Brown M., Kishida T., Yao M., Teh B.T., Latif F., Maher E.R. Br. J. Cancer 98:496-501(2008) · Mapped (1) |
| Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas. Haven C.J., van Puijenbroek M., Tan M.H., Teh B.T., Fleuren G.J., van Wezel T., Morreau H. Clin. Endocrinol. (Oxf) 67:370-376(2007) · Mapped (14) |
| DOK4/IRS-5 expression is altered in clear cell renal cell carcinoma. Al-Sarraf N., Reiff J.N., Hinrichsen J., Mahmood S., Teh B.T., McGovern E., De Meyts P., O'byrne K.J., Gray S.G. Int. J. Cancer 121:992-998(2007) · Mapped (2) |
| Patterns of somatic mutation in human cancer genomes. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C. et al. Nature 446:153-158(2007) · UniProtKB (453) |
| Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. Daly A.F., Vanbellinghen J.-F., Khoo S.K., Jaffrain-Rea M.-L., Naves L.A., Guitelman M.A., Murat A., Emy P., Gimenez-Roqueplo A.-P., Tamburrano G. et al. J. Clin. Endocrinol. Metab. 92:1891-1896(2007) · UniProtKB (1) |
| VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Evans A.J., Russell R.C., Roche O., Burry T.N., Fish J.E., Chow V.W., Kim W.Y., Saravanan A., Maynard M.A., Gervais M.L. et al. Mol. Cell. Biol. 27:157-169(2007) · Mapped (24) |
| Parafibromin inhibits cancer cell growth and causes G1 phase arrest. Zhang C., Kong D., Tan M.H., Pappas D.L. Jr., Wang P.F., Chen J., Farber L., Zhang N., Koo H.M., Weinreich M. et al. Biochem. Biophys. Res. Commun. 350:17-24(2006) · Mapped (2) |
| Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. Gray S.G., Iglesias A.H., Lizcano F., Villanueva R., Camelo S., Jingu H., Teh B.T., Koibuchi N., Chin W.W., Kokkotou E. et al. J. Biol. Chem. 280:28507-28518(2005) · UniProtKB (7) · Mapped (2) |
| C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Huo L., Sugimura J., Tretiakova M.S., Patton K.T., Gupta R., Popov B., Laskin W.B., Yeldandi A., Teh B.T., Yang X.J. Hum. Pathol. 36:262-268(2005) · Mapped (6) |
| Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma. Lee Y.S., Vortmeyer A.O., Lubensky I.A., Vogel T.W., Ikejiri B., Ferlicot S., Benoit G., Giraud S., Oldfield E.H., Linehan W.M. et al. Clin. Cancer Res. 11:1059-1064(2005) · Mapped (4) |
| Spectral karyotyping of sarcomas and fibroblasts derived from Ink4a/Arf-deficient mice reveals chromosomal instability in vitro. Robertson S.A., Schoumans J., Looyenga B.D., Yuhas J.A., Zylstra C.R., Koeman J.M., Swiatek P.J., Teh B.T., Williams B.O. Int. J. Oncol. 26:629-634(2005) · Mapped (4) |
| A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. Cardinal J.W., Bergman L., Hayward N., Sweet A., Warner J., Marks L., Learoyd D., Dwight T., Robinson B., Epstein M. et al. J. Med. Genet. 42:69-74(2005) · Mapped (12) |
| Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium. Qian C.N., Knol J., Igarashi P., Lin F., Zylstra U., Teh B.T., Williams B.O. J. Biol. Chem. 280:3938-3945(2005) · Mapped (13) |
| Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome. Teh B.T., Howell V.M., Haven C.J., Kahnoski K., Khoo S.K., Petillo D., Chen J., Fleuren G.J., Robinson B.G., Delbridge L.W. et al. Hum. Genet. 114:224-224(2004) · Mapped (2) |
| Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome. Teh B.T., Howell V.M., Haven C.J., Kahnoski K., Khoo S.K., Petillo D., Chen J., Fleuren G.J., Robinson B.G., Delbridge L.W. et al. Hum. Genet. 114:223-223(2004) · Mapped (2) |
